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Abstract
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Although borderline personality disorder (BPD) traits decline from adolescence to adulthood,
comorbid psychopathology such as symptoms of major depressive disorder (MDD), alcohol use
disorder (AUD), and drug use disorders (DUDs) likely disrupt this normative decline. Using a
longitudinal sample of female twins (N = 1,763), we examined if levels of BPD traits were
correlated with changes in MDD, AUD, and DUD symptoms from ages 14–24. A parallel process
biometric latent growth model examined the contributions of genetic and environmental factors to
the relationships between developmental components of these phenotypes. Higher BPD trait-levels
predicted a greater rate of increase in AUD and DUD symptoms, and higher AUD and DUD
symptoms predicted a slower rate of decline of BPD traits from ages 14–24. Common genetic
influences accounted for the associations between BPD traits and each disorder, as well as the
interrelationships of AUD and DUD symptoms. Both genetic and nonshared environmental
influences accounted for the correlated levels between BPD traits and MDD symptoms, but solely
environmental influences accounted for the correlated changes between the two over time. Results
indicate that higher levels of BPD traits may contribute to an earlier onset and faster escalation of
AUD and DUD symptoms, and substance use problems slow the normative decline in BPD traits.
Overall, our data suggests that primarily genetic influences contribute to the comorbidity between
BPD features and substance use disorder symptoms. We discuss our data in the context of two
major theories of developmental psychopathology and comorbidity.
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Borderline personality disorder (BPD) is characterized by affective instability, impulsivity,
impaired social functioning, and identity disturbance (American Psychiatric Association,
2013). BPD is related to a number of negative outcomes including interpersonal and
occupational impairment, and suicide (Skodol et al., 2002). Particularly concerning are the
high rates of comorbidity between BPD and other psychiatric disorders, including major
depressive disorder (MDD), alcohol use disorder (AUD), and illicit drug use disorders
(DUD) (McGlashan et al., 2000; Zanarini et al., 2004; Zimmerman & Mattia, 1999). For
those who meet diagnostic criteria for BPD, lifetime comorbidity rates with MDD and AUD
or DUD have been reported as high as 32.1% and 30.9%, respectively (Grant et al., 2008).
Moreover, the association between BPD and several areas of functional impairment can be
attributed to a general impairment shared between BPD and MDD, AUD, and DUDs
(Lenzenweger, Lane, Loranger, & Kessler, 2007), although there is evidence that BPD
predicts functional impairment over-and-above co-morbid psychopathology (Skodol et al.,
2002). In order to better inform treatment frameworks for BPD, it is especially important to
investigate the developmental origins and etiological influences that contribute to this
comorbidity.

Normative Developmental Change
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In epidemiological samples, BPD prevalence and trait levels decline from mid-adolescence
into young adulthood (Bernstein et al., 1993; Bornovalova, Hicks, Iacono, & McGue, 2009;
Cohen, Crawford, Johnson, & Kasen, 2005; Johnson et al., 2000; Lenzenweger, 1999).
There is also evidence for similar declines in adolescents and adults with clinically elevated
levels of BPD symptoms (Cohen et al., 2005; Grilo et al., 2004; Johnson et al., 2000;
Lenzenweger, 1999; Meijer, Goedhart, & Treffers, 1998; Paris, Brown, & Nowlis, 1987;
Shea et al., 2002; Zanarini, Frankenburg, Hennen, & Silk, 2003). The normative decline in
BPD levels is likely due to developmental changes associated with personality maturation.
Indeed, declines in the normal range personality traits of negative emotionality and
behavioral disinhibition – traits that are core to the definition of BPD – show most
pronounced changes from late adolescence to young adulthood (Durbin et al., 2016; Johnson
et al., 2007; Roberts, Caspi, & Moffitt, 2001). In contrast, MDD prevalence rates spike in
mid-adolescence and increase into young adulthood, after which they remain relatively
stable. Risk for AUD and DUD increases in late adolescence, peaks in young adulthood, and
then shows a substantial decline by age 30 (Chassin, Flora, & King, 2004; Compton,
Thomas, Stinson, & Grant, 2007; Costello, Mustillo, Erkanli, Keeler, & Angold, 2003;
Merikangas et al., 2010; Wittchen, Nelson, & Lachner, 1998). The rise and subsequent
decline in AUD and DUD symptoms likely represents extreme versions of maturational
changes in behavioral disinhibition. Likewise, the rise in MDD symptoms during
adolescence likely represents maladaptive variation in neuroticism and social problemsolving (Keller & Nesse, 2005; Moffitt, 1993; Nettle, 2006; Watson & Andrews, 2002).

Evidence for Common Cause, Predisposition, and Pathoplasty Models
Several models have been proposed to account for personality-psychopathology
associations, most notably the predisposition, pathoplasty, and common cause models
(Durbin & Hicks, 2014). The predisposition model posits that BPD traits increase risk for
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the onset of a new disorder. The pathoplasty model predicts that BPD traits affect the course
of disorders, such that higher BPD traits contribute to greater severity and/or chronicity of a
disorder. The common cause model posits that some third variable, such as emotion
dysregulation or disinhibition, accounts for the comorbidity between BPD traits and other
disorders. While each of these models could independently account for BPDpsychopathology associations, it is important to note that they can operate simultaneously.
Also, these models ignore normative developmental shifts in the mean-levels of traits and
the prevalence of disorders, and thus do not account for how these age-related changes might
contribute to the comorbidity between BPD traits and other disorders.
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The common cause model has received the majority of empirical attention and suggests that
BPD traits and symptoms of comorbid disorders are derived partly from shared
neurobiological influences. Seminal theories posit that BPD traits result partly from the
interplay between the same environmental risk (e.g., traumatic life events) and pre-existing,
biologically influenced tendencies that exacerbate comorbid disorders, such as negative
emotionality, sensitivity to emotional cues, and behavioral disinhibition (Linehan, 1993).
Given that impulsivity is related to BPD traits, AUD, and DUD symptoms throughout
development, it has received special attention in efforts to identify a common diathesis
(Berlin, Rolls, & Iversen, 2005; Brodsky et al., 2001; De Wit, 2009; Dick et al., 2010).
Recent models of BPD further emphasize developmental processes that contribute to
heterotypic continuity (Kaufman, Crowell, & Stepp, 2015) and include evidence from
behavior genetic methodology and neuroimaging to support the notion that impulsivity is a
common feature of BPD traits and AUD and DUD symptoms (Beauchaine, Klein, Crowell,
Derbidge, & Gatzke-Kopp, 2009; Crowell, Beauchaine, & Linehan, 2009). These models
posit that the expression of an underlying biological system for a phenotype, such as trait
impulsivity (Coccaro et al., 1989; Friedel, 2004), can gives rise to multiple maladaptive
phenotypic outcomes in the context of other biological and environmental influences
(Beauchaine et al., 2009). Similarly, neuroticism has been considered as one possible source
in BPD-MDD comorbidity (Distel et al., 2009; Hettema, Neale, Myers, Prescott, & Kendler,
2006; Soldz, Budman, Demby, & Merry, 1993; Trull, 1992; Clarkin, Hull, Cantor,
Sanderson, 1993; Soldz, Budman, Demby, & Merry, 1993).

Author Manuscript

Building on well-established evidence that differences in neural responses to rewarding
stimuli covary with impulsivity (Martin & Potts, 2004; Wilbertz et al., 2012), recent
neuroimaging evidence suggests that reduced activation in neural regions that process
rewards are associated with higher levels of BPD traits, such as self-injurious behavior
(Sauder, Derbidge, & Beauchaine, 2016). Similar findings have been observed in
participants with MDD symptoms and elevated alcohol or substance use (Beck et al., 2009;
Jentsch & Taylor, 1999; Must et al., 2006). Further evidence suggests that BPD patients and
participants with lesions in brain regions associated with reward processing, such as the
orbitofrontal cortex, exhibit elevated impulsivity, inappropriate behavior, and other common
BPD characteristics compared with a control group (Berlin, Rolls, & Iversen, 2005; Forbes
et al., 2009). With respect to the BPD-MDD comorbidity, recent neuroimaging work
suggests that variability in structure and function of the prefrontal cortex, anterior cingulate,
hippocampus, and amygdala may represent a neurobehavioral risk factor for development of
neuroticism that has downstream effects on BPD and MDD comorbidity (Cremers et al.,
Dev Psychopathol. Author manuscript; available in PMC 2018 February 01.
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2010; Davidson, Pizzagalli, Nitschke, & Putnam, 2002; DeYoung et al., 2010; Driessen et
al., 2000; Haas, Omura, Constable, & Canli, 2007; Hazlett et al., 2005; Soloff et al., 2003;
Tzschoppe et al., 2014). These data emphasize the importance of neurodevelopmental
influences on BPD and commonly comorbid psychopathology, and provide suggestive
evidence that the common cause model may partially explain co-development and change in
BPD traits and symptoms of comorbid psychopathology. However, a longitudinal test of the
common cause model is needed.

Author Manuscript

In a prior study with a subset of the present sample, we provided a test of the predisposition
model for BPD traits and a composite of substance use (tobacco, alcohol, and marijuana
quantity and frequency) in 14 and 18 year old female twins (Bornovalova, Hicks, Iacono, &
McGue, 2013). BPD traits and substance use were correlated at each age, but BPD traits at
age 14 did not predict substance use at age 18 after accounting for the stability of BPD traits
and substance use (and vice versa). These results were consistent with a common cause but
not predisposition model; however, they failed to rule out the pathoplasty model.
Additionally, while this study focused on quantity and frequency of substance use, it did not
examine the association with substance use disorder symptoms.

Author Manuscript
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Finally, there is accumulating evidence for the pathoplasty model. For example, recurrent or
chronic MDD is associated with a failure to exhibit normative declines in the personality
trait of stress reaction, while persistent AUD is associated with a lack of normative decline
in aggression and behavioral disinhibition (Durbin & Hicks, 2014). Given the strong
connection between BPD traits and these normal-range personality traits, it is also likely that
BPD traits will fail to decline when accompanied by chronic MDD and substance use
disorder symptoms; conversely, the remission of comorbid disorders may facilitate a
reduction in BPD traits. For instance, a large community sample of adolescent females
reported that increasing BPD symptoms were associated with worsening social and mental
health outcomes (Wright, Zalewski, Hallquist, Hipwell, & Stepp, 2015). Likewise, adult
clinical samples report that the rate of decline in BPD traits is associated with the rate of
decline for the personality trait of neuroticism (Wright, Hopwood, & Zanarini, 2015), as
well as decline in co-occurring MDD, AUD, and DUD symptoms (De Panfilis et al., 2011;
Gunderson et al., 2008; Zanarini et al., 2011; Zanarini Frankenburg, Hennen, Reich, & Silk,
2004). Data from the Collaborative Longitudinal Personality Disorder Study, for instance,
indicated that patients with BPD and MDD negatively impacted each other’s time to
remission and accelerated time to relapse (Grilo et al., 2005; Gunderson et al, 2014); similar
results have been reported for substance use disorders (Walter et al., 2009). Likewise, results
from the McLean Study of Adult Development have repeatedly documented that initial
levels and remission status in BPD predict change in major depressive, drug, and alcohol use
disorders (and vice versa; Frankenburg, Fitzmaurice, & Zanarini, 2014; Zanarini et al., 2004;
Zanarini et al, 2011; Zanarini, Frankenburg, Hennen, Reich, & Silk, 2005).

Current Study
We sought to advance our understanding of the association between BPD traits and
symptoms of comorbid disorders in a number of ways. First, we focused on examining both
the pathoplasty and common cause models of BPD traits and AUD, DUD, and MDD
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symptoms (due to the lack of support in our prior research with this sample, we did not
examine the predisposition model). By including symptoms of multiple disorders we were
able to examine convergent and discriminant processes contributing to BPD trait-levels and
symptoms of commonly co-occurring disorders. Second, we extended the developmental
period of interest from age 14 to 24, a period when there are declines in BPD traits and large
increases in MDD, AUD, and DUD symptoms. Notably, most studies that have examined the
comorbidity between BPD traits and other disorders have used adult samples (Gunderson et
al., 2008; Zanarini et al., 2004) with less developmental change in these traits and disorders.
Third, we used our twin sample to estimate genetic and environmental contributions to BPD
traits and their overlap with symptoms of the disorders. Several large cross-sectional studies
have investigated both the heritability of BPD traits (Distel et al., 2011; Distel et al., 2009;
Distel et al., 2008; Kendler et al., 2008; Kendler et al., 2011; Reichborn-Kjennerud et al.,
2015; Reichborn-Kjennerud et al., 2010; Torgersen et al., 2008; Torgersen et al., 2000) as
well as the genetic and environmental overlap between BPD traits and MDD, AUD, and
DUD symptoms in adults (Distel et al., 2012; Kendler et al., 2011). The current study
extends this work to modeling the etiological influences on longitudinal relationships as
well. Finally, we modeled the cross-sectional and longitudinal relationships between BPD
features and MDD, AUD, and DUD symptoms simultaneously. This allowed us to test the
common cause and pathoplasty models for multiple disorders, thereby connecting the
current study to the broader developmental psychopathology literature.

Author Manuscript

A small but growing literature indicates that BPD tendencies are influenced roughly equally
by additive and non-additive genetic (35–50%) and non-shared environmental (50–60%)
sources (Distel et al., 2009; Distel et al., 2008; Kendler et al., 2008; Kendler et al., 2011),
Genetic factors account for much of the association between BPD traits with AUD and DUD
symptoms in adults (Bornovalova et al., 2013; Distel et al., 2012; Kendler et al., 2011),
whereas the association with MDD symptoms is largely accounted by environmental factors
(Kendler et al., 2011). These previous studies have been almost exclusively cross-sectional
and focused on adults. We hoped to extend this work to the co-development between BPD
traits and symptoms of multiple disorders from mid-adolescence through young adulthood.

Author Manuscript

We also capitalized on the longitudinal nature of the data to fit biometric latent growth
models to better understand the co-development between BPD traits and symptoms of
MDD, AUD, and DUD (as well as the interrelationships within MDD, AUD, and DUD
symptoms). Evidence consistent with the common cause model exists if there are significant
correlations between the intercepts (average levels) and slopes (linear rate of change) for
BPD traits and symptoms of MDD, AUD, and DUD. Common cause would also be inferred
if common genetic or environmental influences accounted for any of the cross-sectional or
longitudinal relationships between BPD traits and MDD, AUD, and DUD symptoms.
Evidence consistent with the pathoplasty model exists if the intercept for BPD traits are
correlated with the slopes of MDD, AUD, and DUD symptoms (and vice versa); that is, if
average levels of BPD traits predicted a more severe course (i.e., greater increase) in
symptoms of the disorder. Likewise, pathoplasty would be inferred if high average levels of
MDD, AUD, and DUD symptoms are associated with a lack of normative declines in BPD
trait levels (i.e., shallower slopes).
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Method
Sample
Participants were adolescent female twins taking part in the Minnesota Twin Family Study
(MTFS), an ongoing population-based, longitudinal study of twins and their families
(Iacono, Carlson, Taylor, Elkins, & McGue, 1999; Keyes et al., 2009). Birth records and
public databases were used to locate more than 90% of families that included a twin birth in
the state of Minnesota from 1975 to 1984 and 1988 to 1994. Eligible twins and their families
were a) living within a one-day drive of Minneapolis with at least one biological parent, and
b) had no mental or physical handicap precluding participation. All protocols were approved
by the institutional review board. Parents and children gave informed consent or assent as
appropriate.

Author Manuscript

The MTFS intake sample includes an 11-year-old and a 17-year-old cohort consisting of
same-sex male and female monozygotic (MZ) and dizygotic (DZ) twins. The current study
focused on the female twins, as the male twins only had BPD data at two assessment time
points. Intake and follow-up assessments are scheduled to coincide with major transitions in
the lives of adolescents and young adults. BPD traits were first assessed at age 14 for the
younger cohort, and at age 17 for the older cohort. Follow-up assessments of BPD traits
were conducted at age 17 and 24 in the younger cohort and at ages 20 and 24 in the older
cohort. In the current study, the cohorts were combined and matched by age of assessment.
The actual ages at each assessment (corrected for in all analyses) were 14.88 (SD = .57),
17.89 (SD = .69), 20.83 (SD = .61), and 25.09 (SD = .73). AUD, DUD, and MDD symptoms
were assessed using the same time points and procedures, then combined and corrected for
age variability in the same manner as BPD traits. Retention rates were excellent with
approximately 90% participation at each wave.

Author Manuscript
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The final sample included 1121 MZ (or identical) twins and 642 DZ (or fraternal) twins. The
sample sizes for each assessment time point were as follows: age 14 (N = 1080; 674 twins
from MZ pairs, 406 twins from DZ pairs); age 17 (N = 1602; 1026 twins from MZ pairs,
576 twins from DZ pairs); age 20 (N = 1389; 879 twins from MZ pairs, 510 twins from DZ
pairs); age 24 (N = 1260; 797 twins from MZ pairs, 463 twins from DZ pairs). Zygosity was
determined by agreement among 3 estimates: MTFS staff evaluations of the twins’ physical
similarity; parents’ completion of a standard zygosity questionnaire; and twin similarity on
an algorithm of ponderal and cephalic indices and fingerprint ridge count. A serological
analysis was performed if the 3 estimates did not agree. Consistent with the racial/ethnic
makeup of the recruitment area, 95.3% of the sample was white. Additionally, the mean
maternal and paternal years of education among the families of origin were 13.57 (2.09) and
13.67 (2.61), respectively.
Measures
BPD Traits—The Minnesota Borderline Personality Disorder Scale (MBPD; Bornovalova,
Hicks, Patrick, Iacono, & McGue, 2011) is a self-report inventory of BPD traits that
provides a dimensional measure of BPD trait severity. The MBPD was developed using
items from the Multidimensional Personality Questionnaire (MPQ; Tellegen, 1982; Patrick,
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Curtin, & Tellegen, 2002) and asks participants to respond to 19-items on a 4-point scale
(agree, somewhat agree, somewhat disagree, disagree). Items for the MBPD were selected
due to overlap with BPD symptomatology and were drawn from the following MPQ scales:
stress reaction (e.g., Mood often fluctuates), alienation (e.g., Often betrayed by friends),
control (e.g., Often act impulsively), aggression (e.g., Sometimes enjoy saying mean things),
well-being (e.g., Rarely feel happy), and absorption (e.g. Sometimes feel presence of people
not actually there). While the MPQ was designed to measure normal personality
functioning, the MBPD scale is correlated with established self-report measures of BPD
traits (rs= 0.80–0.89) and BPD diagnosis and symptom counts (rs = 0.60–0.66, respectively)
from structured interviews in community and clinical samples (Bornovalova et al., 2011;
Rojas et al., 2014; Rojas, Hicks, Stark, Hopwood, & Bornovalova, 2015). MBPD scores also
show high reliability and temporal stability (Rojas et al., 2015) as well as theoretically
expected associations with criterion variables in the BPD trait nomological network, such as
impulsivity, antisocial behaviors, interpersonal problems, MDD symptoms, and alcohol and
drug use (Bornovalova et al., 2011; Bornovalova et al., 2013; Rojas et al., 2013; Rojas et al.,
2015). In this sample, internal consistency reliability was > .80 for all follow-ups, and the
score distributions exhibited minimal skew and kurtosis (< 1 for all time points). Therefore,
MBPD scores can be used to make reasonable inferences about BPD traits. To adjust for any
variability in age at each assessment, the BPD trait data were conditioned on target age (ages
14, 17, 20, or 24 depending on the assessment wave; i.e., age variability around each
assessment point regressed out; Bornovalova et al., 2009; Johnson et al., 2007). Raw scores
are plotted for descriptive purposes in Figure 1. To aid with model fitting in all nondescriptive analyses, MBPD scores were recoded to range between 1 (maximum possible
score) and 0 (minimum possible score) using the following equation: [(MBPD individual
score-min)/(max-min) = (MBPD individual score-19)/57]. This rescaling minimized the
differences in variance between the variables in the models while maintaining all the original
properties of the MBPD scores.

Author Manuscript

MDD, AUD and DUD Symptoms—Symptoms of MDD, AUD, and DUD were assessed
using the Diagnostic Interview for Children and Adolescents – Revised (DICA-R) (Reich &
Welner, 1988), the Structured Clinical Interview for DSM-III-R (Spitzer, Williams, Gibbon,
& First, 1987), and the Substance Abuse Module of the Composite International Diagnostic
Interview (Robbins, Cottler, & Babor, 1990). Clinical interviews were conducted by trained
staff members at the University of Minnesota. Maternal reports of these symptoms were also
collected at ages 14 and 17. Consistent with evidence that each informant provides unique
information in the assessment of psychopathology, we utilized a best estimate approach and
considered a symptom present if reported by either the twin or parent (Burt, Krueger,
McGue, & Iacono, 2003; Burt, Krueger, McGue, & Iacono, 2001). An established diagnostic
consensus procedure was used to maximize accuracy of symptom assignment. For each
participant, a clinical case conference consisting of at least two advanced clinical
psychology graduate students was conducted in which all interview data was reviewed,
referring to audiotapes when necessary. The two diagnosticians were required to reach
consensus regarding symptom presence prior to assigning any symptoms. Once consensus
was reached regarding the presence/absence of symptoms, a computer algorithm was used to
determine diagnosis. The consensus process yielded diagnostic kappa reliabilities that
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ranged from 0.71 to 0.92. All symptom counts were log transformed to reduce skew and
kurtosis (see Table 1 for means and SDs, as well as the range of the raw and log-transformed
scales). As with MBPD scores, the MDD, AUD, and DUD data were conditioned on target
age to account for any variability in age at each assessment.
Analytic Approach

Author Manuscript

We fit a multivariate biometric latent growth model to BPD traits and MDD, AUD, and
DUD symptoms between the ages of 14 and 24. This model allows us to simultaneously
model the developmental trajectories of each phenotype using a set of latent factors that
estimate the average level (intercept) and rate of change (both linear and quadratic) in each
phenotype, as well as the covariance between the latent growth parameters (Molenaar &
Rovine, 1998; Neale & McArdle, 2000; Singer & Willett, 2003).12 Multivariate growth
models allowed us to examine the covariance between the latent growth parameters across
phenotypes, such as a) the correlation between the intercept of BPD traits and the intercept
of the other phenotypes (e.g., do people with higher levels of BPD traits have more
symptoms of other psychopathology?); b) the correlation between the linear slope of BPD
traits and the linear slope of the other phenotypes (e.g., do people who decrease in BPD
traits more slowly also have a faster rate of increase in other symptoms of
psychopathology?), c) the correlation between the intercept of BPD traits and the linear
slope of the other phenotypes (e.g., do people with higher BPD traits increase faster in AUD
symptoms?); d) the correlation between the linear slope of BPD traits and the intercept of
the other phenotype (e.g., do BPD traits decrease more slowly among people with higher
average levels of AUD symptoms?). (a) and (b) provide evidence for common cause,
whereas (c) and (d) provide evidence of pathoplasty.

Author Manuscript
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We used the twin data to decompose the variance of the latent growth parameters into
additive genetic (A - additive effect of individual genes summed over loci on trait variance),
shared environmental (C - environmental influences that increase similarity between
members of a twin pair), and unshared environmental (E - environmental factors that
contribute to differences between members of a twin pair, including measurement error)
variance components. This allowed us to examine genetic and environmental influences on
the co-development between BPD traits and MDD, AUD, and DUD symptoms. To
determine the best fitting model for each phenotype, we progressively dropped parameters
for the variance components and time specific residuals and compared model fit of nested
models to identify a parsimonious model that was consistent across all four phenotypes (see
supplemental materials for model-fitting results). Because the common environmental
factors did not significantly improve the fit of any models, we present the results with these
parameters fixed at zero. Finally, we estimated the genetic and environmental contributions
to covariance between growth parameters for BPD traits and the other phenotypes. A path
depiction of the bivariate growth model for one twin (which generalizes to the multivariate
1For these models, factor loadings on the latent growth factors varied to account for differing measurement intervals. Also, orthogonal
polynomial contrast weights were used for the linear and quadratic loadings to remove non-essential multicollinearity between the
latent factors. The intercept was anchored at the age midpoint (~age 19).
2Negligible variance for higher-order growth factors – such as quadratic growth factors – is common and correlations with parameters
with virtually zero variance are generally uninformative and can lead to empirical under-identification. Accordingly, the models
estimated the variance of the quadratic parameter but not the covariance of the quadratic parameter with the intercept or linear factors.
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case) is presented in Figure 1. All models were fit with Full Information Maximum
Likelihood (which is robust to most forms of missingness) in OpenMx 2.0 (Little & Rubin,
1983; Neale et al., 2016).

Results
Within Trait Biometric Latent Growth Parameters

Author Manuscript
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Descriptive statistics for all of the variables, such as means, standard deviations, and twin
correlations by zygosity for all phenotypes and ages are reported in Table 1. We present the
means, variances, and proportion of additive genetic (A) and unique environmental (E)
variance of the latent growth factors for each phenotype in Table 2, and a spaghetti plot of
the trajectories of each phenotype in Figure 2. Consistent with our previous report, the
negative slope for BPD traits indicated that trait BPD significantly decreased from ages 14 to
24 (Bornovalova et al., 2009). In contrast, MDD, AUD, and DUD symptoms all had positive
linear slopes, indicating that on average there was an increase in symptoms for each disorder
from ages 14 to 24. Biometric model fitting (Table 3) indicated that the best fitting biometric
models included only genetic and nonshared environmental components for the latent
growth factors and residual variances of each phenotype at each assessment. Results from
the biometric variance decompositions (Table 2) revealed that the intercept of each
phenotype was highly heritable (0.64 to 0.78) with small to medium nonshared
environmental influences (0.36 to 0.22). The linear slope for BPD traits and AUD and DUD
symptoms exhibited significant genetic influences (0.33 to 0.65), while the linear slope for
MDD symptoms was mostly determined by non-shared environment influences (0.82).
Finally, although the quadratic variance component did not have sufficient variation to
reliably decompose into genetic and environmental influences, it improved model fit and
was subsequently retained in all models3 .
Cross-Phenotype Biometric Latent Growth Parameters
Table 4 presents the phenotypic correlations, Table 5 presents the additive genetic
correlations, and Table 6 presents the unique environmental correlations for the growth
parameters across the four phenotypes. Because we focused on the relationship between
BPD traits and the three other phenotypes, the first two columns of Tables 4–6 are of
primary interest. The other columns speak to broader co-development of MDD, AUD, and
DUD symptoms.

Author Manuscript

Evidence for common cause—Consistent with the common cause model, the BPD trait
intercept was significantly correlated with the intercepts for MDD, AUD, and DUD
symptoms, indicating that those with higher BPD trait levels tended to experience more
symptoms of MDD, AUD, and DUD. The intercept for BPD traits showed significant
genetic and moderate nonshared environmental correlations with the intercepts of MDD,
AUD, and DUD symptoms (Tables 4 and 5), indicating greater genetic relative to
environmental overlap between BPD traits and the other phenotypes. A similar pattern was
3The confidence intervals for the quadratic term were large and included both 0 and 1. In our models, its correlation with other growth
parameters was fixed to zero. The intercept-slope correlations of the individual phenotypes was included in the models and is reported
elsewhere (Bornovalova et al, 2009).
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evident for MDD, AUD, and DUD symptoms: the intercepts were significantly correlated
with each other, and evidenced similar pattern of genetic and environmental covariation.

Author Manuscript

Next, the linear slope for BPD traits was correlated with the linear slopes for MDD, AUD,
and DUD symptoms. This indicates that after accounting for the average level, greater
increases in symptoms of MDD, AUD, and DUD were associated with a slower decline in
BPD traits. Alternatively, this could be stated as the smaller the increase in symptoms of
MDD, AUD, and DUD, the greater the decline in BPD traits. The genetic correlation
between the slopes was significant and of moderate effect, while the nonshared
environmental correlations were not significant, with one notable exception. The nonshared
environmental correlation between BPD trait slope and MDD symptom slope was moderate
(.47) and significant. No other nonshared environmental correlations approached
significance. Therefore, genetic influences primarily accounted for the associations between
the linear slopes of BPD traits and AUD and DUD symptoms. In contrast, nonshared
environmental influences primarily accounted for the association between the linear slopes
of BPD traits and MDD symptoms. With respect to other phenotypes, MDD symptom slope
predicted AUD but not DUD symptom slope. This relationship was accounted for by
overlapping genetic factors, with no significant evidence for nonshared environmental
overlap. AUD and DUD symptom slopes were significantly correlated, showing strong and
roughly equal influences of common genetic and nonshared environmental factors.

Author Manuscript
Author Manuscript

Evidence for pathoplasty—The intercept for BPD traits was correlated with the linear
slope of AUD and DUD symptoms, but not MDD symptoms. Consistent with the
pathoplasty hypothesis, individuals who had higher levels of BPD traits increased in AUD
and DUD symptoms more rapidly. Furthermore, the nonshared environmental correlations
between BPD trait intercept and the linear slopes of AUD and DUD symptoms were
significant and contributed more to the covariance than genetic factors. The linear slope for
BPD traits was negatively correlated with the intercepts of AUD and DUD symptoms, and
unrelated to the MDD symptoms intercept. This indicates that individuals with more AUD
and DUD symptoms were associated with a slower rate of decline in BPD traits, even after
adjusting for the average trait level. The associations between the linear slope of BPD traits
and the intercepts of AUD and DUD symptoms were almost entirely due to genetic
influences. As for the other phenotypes, MDD symptom intercept was positively correlated
with AUD and DUD symptom slope (but not vice versa), with this relationship accounted
for solely by genetic overlap. Unsurprisingly, AUD symptom intercept was correlated with
DUD symptom slope (and vice versa), with somewhat more robust nonshared environmental
than genetic overlap. Taken together, the slope-intercept correlations across all four
phenotypes suggest that an individual’s comorbid psychopathology is associated with the
trajectory of other maladaptive traits.

Discussion
Using a large, longitudinal twin sample, we conducted the first study to investigate the
genetic and environmental influences on the co-development between BPD traits and MDD,
AUD, and DUD symptoms from middle adolescence to young adulthood. Previous studies
have reported that BPD traits tend to decline over time, and that declines in BPD traits are
Dev Psychopathol. Author manuscript; available in PMC 2018 February 01.
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associated with declines in the symptoms of comorbid disorders (Bornovalova et al., 2009;
Gunderson et al., 2008; Lenzenweger, 1999). Few studies, however, have considered the
developmental context of the associations between BPD traits and symptoms of other
disorders—specifically, during a period when there are dramatic changes in the mean-levels
of BPD traits, MDD, AUD, and DUD symptoms—allowing for hypotheses about
developmental processes that might contribute to these associations. Next, no study has
examined the genetic and environmental influences on the co-development between BPD
traits and symptoms of other disorders. Finally, the current paper simultaneously modeled
the total, genetic, and nonshared environmental correlations between BPD traits, MDD,
AUD, and DUD symptoms. Results from this model align the current paper with the broader
models within developmental psychopathology that suggest that disorders rarely develop
discretely and independently. Rather, there is an interdependence and interaction among
multiple forms of psychopathology that necessitate a whole-organism approach.

Author Manuscript

In terms of developmental change, we replicated previous epidemiological findings that
BPD traits decreased, while symptoms of MDD, AUD, and DUD increased from ages 14 to
24 (Chen & Jacobson, 2012; Dussault, Brendgen, Vitaro, Wanner, & Tremblay, 2011). The
decline in BPD traits was consistent with longitudinal research on normal personality
development that finds large declines in negative emotionality and behavioral disinhibition
during the transition from adolescence into young adulthood (Johnson et al., 2000; Roberts,
Walton, & Viechtbauer, 2006). Our findings suggest similar maturational processes may
contribute to age-related declines in BPD traits.

Author Manuscript

The current results support two models of comorbidity: the common cause model and the
pathoplasty models. For common cause, we detected medium to large associations between
a) the average level of BPD traits and the average levels of the other disorders and b)
changes in BPD traits and changes in other disorders associations. Consistent with previous
work (Distel et al., 2012; James & Taylor, 2008; Kendler et al., 2011), these associations
were primarily due to genetic influences. Beyond BPD, there were large genetic correlations
between MDD, AUD, and DUD as well. The data suggest that there are transdiagnostic,
heritable influences (e.g., temperament traits) that contribute to the average level as well as
the covariation in change of BPD traits, MDD, AUD, and DUD symptoms from ages 14 to
24.

Author Manuscript

Importantly, correlated rates of change provide especially strong evidence of a common
cause model, suggesting that a similar process is affecting fluctuations in both BPD traits
and symptoms of other psychopathology. Also consistent with a common cause model, there
was substantial genetic and environmental overlap between the intercepts and slopes among
BPD traits, AUD, DUD, and MDD symptoms. Interestingly, genetic influences primarily
accounted for the correlated changes between BPD traits and AUD and DUD symptoms,
while environmental influences primarily accounted for the correlated changes between
BPD traits and MDD symptoms. Also, the correlations between the slope for BPD traits and
the changes in AUD and DUD symptoms were small, while the correlation between the
slope of BPD traits and MDD symptoms was large. Consistent with previous cross-sectional
reports (Kendler et al., 2011), common nonshared environmental factors also accounted for
the correlated slopes between BPD traits and MDD symptoms. The large, nonshared
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environmental correlation stands in contrast to the moderate to large genetic correlations
between the growth parameters for BPD traits and AUD and DUD, and suggests that a
markedly different process is driving the correlated rates of change between BPD traits and
MDD symptoms. While complex processes involving both genetic and environmental
factors likely contribute to the co-development of BPD traits and symptoms of commonly
comorbid psychopathology, it is possible that environmental experiences (e.g., stressful life
events, changes in relationships) have more pronounced effects on correlated changes in
both BPD traits and MDD symptoms, with more gradual maturational changes in heritable
characteristics (e.g., behavioral disinhibition) accounting for the majority of correlated
changes between BPD traits and AUD and DUD symptoms.

Author Manuscript

On a broader level, the genetic correlations among the multiple forms of psychopathology
are consistent with recent findings from molecular genetic research (Lichtenstein, Carlstrom,
Rastam, Gillberg, & Anckarsater, 2010; Maier et al., 2015). The cross-disorder group from
the Psychiatric Genetics Consortium, for instance, reported that some genetic risk factors
seem to be shared across multiple disorders (attention deficit hyperactivity disorder, autism
spectrum disorder, bipolar disorder, MDD, and schizophrenia; Smoller et al., 2013). Like
previous work, our results provide support for the common cause and pathoplasty models
across multiple forms of psychopathology. However, unlike existing molecular genetic work,
we were able to model longitudinal relationships. This allowed us to begin disentangling
common cause and pathoplasty at a finer level.

Author Manuscript

Given our results, an obvious question concerns identification of the common causes
underlying the co-development between BPD traits and symptoms of other disorders. One
possibility is common genetic variants influence both disorders – a possibility that should be
explored in the cross-disorder group of the Psychiatric Genetics Consortium. As briefly
alluded to above, a likely answer is that broad neurobehavioral processes such as negative
emotionality, rejection sensitivity, emotional dysregulation, or behavioral disinhibition have
non-specific effects and contribute to a diverse set of phenotypes including internalizing and
externalizing disorders (Beauchaine, Gatzke-Kopp, & Mead, 2007; Iacono et al., 1999;
Lenzenweger, 2010; Lilienfeld, 2003; Silk, Steinberg, & Morris, 2003; Young et al., 2009).
With regard to behavioral disinhibition, the literature clearly documents elevated impulsivity
in patients with BPD, AUD, and DUDs (Lee, Bagge, Schumacher, & Coffey, 2010; Links,
Heslegrave, Mitton, Vanreekum, & Patrick, 1995; Wilson, Fertuck, Kwitel, Stanley, &
Stanley, 2006) – suggesting that the latter serves as a process common to the two disorders
(Bornovalova, Lejuez, Daughters, Rosenthal, & Lynch, 2005; Trull, Sher, Minks-Brown,
Durbin, & Burr, 2000).

Author Manuscript

Common neurobiological changes throughout development may account for the correlated
slopes between BPD traits and AUD and DUD symptoms. Developmental imaging studies
suggest that the brain systems governing the socioemotional, cognitive, and decision-making
processes that contribute to disinhibited behavior exhibit dramatic remodeling during middle
and late adolescence (Spear, 2010; Wahlstrom, White, & Luciana, 2010). Distinct changes in
adolescent neural processing of social and emotional information are thought to impact the
functioning of the prefrontal cortex and subsequent self-regulation of motivational states and
impulsive behavior (Ernst & Fudge, 2009; Spear, 2010; Steinberg, 2007). Notably,
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development of these networks involve changes in the amygdala, nucleus accumbens,
orbitofrontal cortex, medial prefrontal cortex, and superior temporal sulcus (Nelson,
Leibenluft, McClure, & Pine, 2005) that occur at the same time as a dramatic remodeling of
the dopaminergic neural reward system (Spear, 2000; Wahlstrom et al., 2010). The reward
system also shows enhanced responsivity to anticipating and receiving rewards of
disinhibited behavior in adolescence relative to adulthood (Bjork et al., 2004; Ernst &
Fudge, 2009; Geier, Terwilliger, Teslovich, Velanova, & Luna, 2010; Joseph, Liu, Jiang,
Lynam, & Kelly, 2009). Cross-sectionally, structural and functional variability in these
systems has been documented in BPD, AUDs, and DUDs (Bowirrat & Oscar-Berman, 2005;
Everitt & Robbins, 2005; Friedel, 2004; Hyman, Malenka, & Nestler, 2006; Kelley &
Berridge, 2002; Koob, 1992; Makris et al., 2008; Wrase et al., 2007). Competition between
the socioemotional and cognitive control system (Drevets & Raichle, 1998), altered timing
in the maturation of these systems (Steinberg, 2007), or incomplete functional integration of
neural signals implicated in the socioemotional and cognitive control systems (Stevens,
2009) may be driving the correlated changes in BPD, AUD, and DUD as well. While the
latter notion is speculative, data from large, epidemiological projects that include imaging
(e.g., Adolescent Brain and Cognitive Development; National Consortium on Alcohol and
Neurodevelopment in Adolescence) will be able to test it empirically.

Author Manuscript

Several findings were also consistent with the pathoplasty model. First, average levels of
BPD traits were associated with greater increases in AUD and DUD symptoms, suggesting
that BPD traits increase the likelihood of a transition from use to problem use and the
escalation of AUD and DUD symptoms. Likewise, AUD and DUD symptoms were
associated with a slower decline in BPD traits, suggesting substance use disorder symptoms
disrupt maturational processes and contribute to the persistence of BPD traits. This result is
consistent with other studies of BPD comorbidity in adolescence and adulthood (Burke &
Stepp, 2012; Rohde, Lewinsohn, Kahler, Seeley, & Brown, 2001; Zanarini et al., 2004). For
instance, Zanarini et al. (2004) reported that the absence of substance use disorders at a 6year follow-up was the strongest predictor of the remission of BPD in patients diagnosed
with BPD.

Author Manuscript

Additionally, pathoplasty was evident for symptoms of MDD on AUD and DUD symptoms.
That is, higher mean-levels of MDD symptoms were associated with greater increases in
symptoms of AUD and DUD. Notably, this association was not reversed; that is, greater
mean-levels of AUD and DUD symptoms were not associated with changes in MDD
symptoms. Prior work on has provided mixed evidence on the temporal ordering of MDD
and substance use problems, with some studies reporting that drug and alcohol use predicts
MDD levels (Bovasso, 2001; Rohde et al., 2001; Stice, Burton, & Shaw, 2004), others that
MDD symptoms predict substance use symptoms (Abraham & Fava, 1999), and still others
reporting reciprocal relationships (Hettema, Prescott, & Kendler, 2003). Differences in
sample composition and measurement approaches may account for many of the disparities.
Our results suggest that unipolar mood symptoms are indicative of a more severe and
persistent course of AUDs and DUDs.
When examining the evidence for the common cause and the pathoplasty hypotheses, two
important observations should be underscored. First, it appears that the evidence for
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pathoplasty is more associated with unique environmental factors, while the evidence for
common cause is more associated with common/shared genetic factors, with the notable
exception of the MDD intercept correlations with AUD and DUD linear slopes. Second, the
magnitudes of the relationships that support the common cause hypothesis are slightly
stronger than those that support the pathoplasty hypothesis.

Author Manuscript
Author Manuscript

Although unique, these findings are qualified by several limitations. First, nearly all
participants were females of European American ancestry, limiting generalizability. BPD has
traditionally been investigated in samples of middle to upper class, educated Caucasian
females in psychiatric inpatient facilities (Silk, Lee, Hill, & Lohr, 1995; Zanarini,
Frankenburg, Khera, & Bleichmar, 2001; Zanarini et al., 2002). However, it is possible that
BPD-psychopathology relationships may differ across gender and ethnic groups, particularly
considering evidence that rates of psychopathology, including personality disorders, differ
across racial/ethnic groups (McGilloway, Hall, Lee, & Bhui, 2010; Turner & Gil, 2002).
Second, the rate of BPD diagnosis is unknown in the current sample. Nevertheless, rates of
similar disorders (e.g., antisocial personality disorder) are consistent with large,
representative samples (Hamdi & Iacono, 2014). Third, the MBPD scale is a self-report
questionnaire (albeit, well-validated) that provides a dimensional/trait rather than symptom
measure of BPD. In contrast, MDD, AUD, and DUD symptoms were clinician-determined
symptom counts. The differences in measurement introduce the potential concern of method
effect that is not accounted for in the data, and likely reduces the effect sizes between BPD
traits and the disorders given the different method of measurement. While interviews are
often assumed to be superior to questionnaire measures, there is limited evidence for the
incremental validity of one method over the other, though each approach has particular
strengths and weaknesses (Hopwood et al., 2008). Ideally, the current study should be
replicated using a multi-method (i.e., trait- and interview-based measures) approach. Finally,
the current study was not set up to arbitrate between common cause and pathoplasty
hypotheses (although the two may operate simultaneously).

Author Manuscript

Together, our results are indicative of meaningful co-developmental processes between BPD
traits and MDD, AUD, and DUD symptoms. Moreover, our results further highlight the
construct validity of the MBPD. The availability of a quantitative and dimensional measure
of BPD traits that can be applied in a general population sample will further bridge the gap
between psychopathology and normal behavior – a perspective consistent with the National
Institute of Mental Health’s Research Domain Criteria framework (Insel et al., 2010). Our
results set the stage for several future studies. The most apparent follow-up study would
investigate temperamental and environmental processes that account for the genetic and
environmental correlations between BPD traits and MDD, AUD, and DUD symptoms. One
approach is to test if there is a corresponding reduction in the genetic correlation between
BPD traits and AUD symptoms after accounting for a preexisting vulnerability (e.g.,
behavioral disinhibition). Next, this work should be replicated in another sample –
preferably using a multi-method approach to the measurement of psychopathology.
Likewise, this study should be replicated using males and more diverse samples. Finally,
there is a clear need to extend these models of comorbidity into middle and late adulthood,
as there is a clear drop-off in our understanding of BPD comorbidity past middle adulthood.
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Exploration of these questions will provide further insight into etiological influences on
BPD and its comorbidity with other psychopathology throughout the lifespan.
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Figure 1.
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Bivariate Growth Model for One Twin
Note: BPD refers to Borderline Personality Disorder traits, while AUD refers to Alcohol Use
Disorder symptoms. In the full model, BPD traits, AUD, MDD, and DUD were included. An
abbreviated figure is presented to increase clarity. Each assessment point is assumed to
reflect an effect of general level of the phenotype/intercept (I), linear slope (S), and
quadratic slope (Q), and assessment-specific additive genetic (A), shared environmental (C),
and nonshared environmental effects (E). The intercept and slope effects are also
decomposed into correlated additive genetic, shared environmental, and nonshared
environmental effects. Subscripted numbers refer to the age of measurement, and numbers
above the grey paths coefficients indicate fixed factor loadings for the growth parameters.
Common Environmental effects were estimated in the fully saturated model but they were
subsequently removed, as they did not improve the fit of the model.
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Figure 2.
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Predicted Growth trajectories for Borderline Personality Disorder traits, Major Depressive
disorder symptoms, Alcohol Use Disorder symptoms, and Drug Use Disorder symptoms.
Note: Each point in the graphs represent expected means for the respective phenotype, while
the black lines depict mean trajectories. The surrounding lines are 250 randomly sampled
individuals from the dataset that illustrate variability around the mean trajectory. MDD,
AUD, and DUD symptom variables underwent a log+1 transformation for all analyses, and
log-transformed data are plotted above. MBPD was recoded to range between 1 (maximum
possible score) and 0 (minimum possible score) [(MBPD individual score-min) (max-min) =
(MBPD individual score-19)/57).
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Descriptive statistics and twin Correlations and 95% CIs for Borderline Personality Disorder (BPD) traits, Major Depressive Disorder (MDD) symptoms,
Alcohol Use Disorder (AUD) symptoms, and Drug Use Disorder (DUD) symptoms across ages 14 to 24
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.36 (.30, .43)

Proportion E Variance

.67 (.40, .86)

Proportion E Variance

.01 (.00, .01)
.00 (.00, .30)
1.00 (.70, 1.00)

Total Variance

Proportion A Variance

Proportion E Variance

−.01 (−.02, .00)

.33 (.14, .62)

Proportion A Variance

Mean

.02 (.01, .02)

Total Variance

−.12 (−.14, −.11)

.64 (.57, .71)

Proportion A Variance

Mean

.02 (.01, .02)

.41 (.40, .42)

Total Variance

Mean

1.00 (.00, 1.00)

.00 (.00, 1.00)

.03 (.00, .13)

−.15 (−.21, −.09)

.82 (.38, 1.00)

.18 (.00, .62)

.34 (.17, .53)

.49 (.42, .55)

.36 (.23, .50)

.64 (.50, .77)

.14 (.12, .17)

1.08 (1.05, 1.12)

MDD Symptoms

1.00 (.64, 1.00)

.00 (.00, .36)

.03 (.02, .04)

−.08 (−.10, −.05)

.50 (.32, .69)

.50 (.31, .68)

.17 (.14, .20)

.24 (.21, .27)

.26 (.17, .36)

.74 (.64, .83)

.06 (.05, .06)

.20 (.18, .22)

AUD Symptoms

.24 (.00, .86)

.76 (.14, 1.00)

.02 (.01, .04)

−.07 (−.10, −.05)

.36 (.23, .47)

.65 (.53, .77)

.18 (.14, .21)

.10 (.07, .14)

.23 (.17, .29)

.78 (.71, .83)

.06 (.05, .07)

.13 (.11, .15)

DUD Symptoms

Note: All symptom counts were subjected to a log transformation [log(x+1)] to reduce skew and kurtosis. To aid with model fitting, MBPD was recoded to range between 1 (maximum possible score) and 0
(minimum possible score) [(MBPD individual score-min) (max-min) = (MBPD individual score-19)/57); accordingly, the intercept can be interpreted as the level (form 0 to 1), and the slope can be
interpreted as percent change over the 10 year interval.

Quadratic Slope

Linear Slope

Intercept

BPD Traits

Model Predicted Means and Total Variances and Standardized Genetic and Unique Environmental Variance Components of Borderline Personality
Disorder (BPD) traits, Major Depressive Disorder (MDD) symptoms, Alcohol Use Disorder (AUD) symptoms, and Drug Use Disorder (DUD) symptoms
for the univariate phenotypes.
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17
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No Correlation between Latent Growth Factors

No A Component for the Latent Growth Factors

No E Component for the Latent Growth Factors

No Specific A Component for the time points

19
17
15
15
15

No Common Environment*

No Correlation between Latent Growth Factors

No A Component for the Latent Growth Factors

No E Component for the Latent Growth Factors

No Specific A Component for the time points

Dev Psychopathol. Author manuscript; available in PMC 2018 February 01.
19
17
15
15
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No Common Environment*

No Correlation between Latent Growth Factors

No A Component for the Latent Growth Factors

No E Component for the Latent Growth Factors

No Specific A Component for the time points

27
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Full Model

No Common Environment*

No Correlation between Latent Growth Factors

No A Component for the Latent Growth Factors

No E Component for the Latent Growth Factors

Drug Use Disorder Symptoms

27

Full Model

Alcohol Use Disorder Symptoms

27

Full Model

Major Depressive Disorder Symptoms

19

27

ep

No Common Environment*

Full Model

Borderline Personality Disorder Traits

Model

3050.72

3200.70

3130.05

2982 .00

2979.85

4191.17

4158.97

4260.9

4214.28

4104.01

4102.93

11492.39

11408.97

11425.13

11382.73

11369.94

11362.79

−5061.39

−4875.07

−4876.55

−5074.85

−5079.28

−5083.33

−2LL

5289

5289

5287

5285

5277

5291

5291

5291

5289

5287

5279

5289

5289

5289

5287

5285

5277

4325

4325

4325

4323

4321

4313

df

−7527.28

−7377.3

−7443.95

−7588

−7574.153

−6390.83

−6423.03

−6321.1

−6363.72

−6469.99

−6455.067

914.39

830.97

847.13

808.73

799.94

808.7853

−13711.39

−13525.07

−13526.55

−13720.85

−13721.28

−13709.33

AIC

68.72

218.7

148.05

87.17

54.97

156.9

110.27

122.45

39.02

55.19

12.79

17.89

204.21

202.73

4.43

-

−2LL

4

4

2

4

4

4

2

4

4

4

2

4

4

4

2

-

df

.000

.000

.000

.000

.000

.000

.000

.000

.000

.000

.002

.000

.000

.000

.109

-

p

Biometric model fitting results for the Univariate Latent Growth Models for Borderline Personality Disorder (BPD) traits, Major Depressive Disorder
(MDD) symptoms, Alcohol Use Disorder (AUD) symptoms, and Drug Use Disorder (DUD) symptoms.
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3037.44

5289

−7540.56

AIC
55.44

−2LL
4

df
.000

p

As the common environment did not significantly contribute to variation in any of the phenotypes, it was dropped from the analysis. Accordingly, the No Common Environment model is the model against
which subsequent reduced models were tested, and it was always the best fitting model.

*

Note: ep, estimated parameters; −2LL, −2 log likelihood; AIC, Akaike Information Criterion.
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1.00

.32 (.26, .39)

.11 (.02, .19)

DUD intercept

DUD slope
.15 (.05, .27)

−.15 (−.26, −.06)

.49 (.33, .71)

.02 (−.09, .13)

.17 (.06, .29)

−.12 (−0.22, −0.02)

1.00

BPD slope

.24 (.14, .34)

.71 (.65, .76)

.11 (−.02, .25)

.39 (.30, .48)

.57 (.49, .63)

1.00

AUD intercept

.59 (.49, .68)

.38 (.29, .47)

.23 (.08, .38)

.26 (.16, .37)

1.00

AUD slope

.24 (.14, .35)

.46 (.38, .53)

.35 (.18, .53)

1.00

MDD intercept

.05 (−.09, .19)

−.11 (−.23, .02)

1.00

MDD slope

.56 (.48, .64)

1.000

DUD intercept

1.00

DUD slope

Note: Key relationships of interest between BPD intercept and slope and the intercept and slope of MDD, AUD, and DUD are separated by vertical lines. All significant relationships are bolded.

.56 (.49, .63)

.02 (−.09, .14)

MDD slope

.26 (.18, .35)

MDD intercept

.44 (.37, .50)

AUD slope

−.02 (−.15,.07)

AUD intercept

BPD slope

BPD intercept

BPD intercept

Total correlations between the latent growth parameters for Borderline Personality Disorder (BPD) traits, Major Depressive Disorder (MDD) symptoms,
Alcohol Use Disorder (AUD) symptoms, and Drug Use Disorder (DUD) symptoms.
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.18 (.03, .33)
.62 (.51, .74)

.22 (−.12, .56)
.37 (.27, .47)

.06 (−.08, .19)

AUD slope

MDD intercept

MDD slope

DUD intercept

DUD slope
.36 (.12, .64)

−.20 (−.42, −.01)

.55 (−.05, .95)

.00 (−.27, .28)

.45 (.18, .78)

−.24 (−.49, −.02)

1.00

BPD slope

.11 (−.04, .26)

.72 (.63, .80)

−.02 (−.48, .32)

.41 (.26, .56)

.41 (.25, .53)

1.00

AUD intercept

.60 (.44, .77)

.31 (.17, .46)

.59 (.12, .94)

.36 (.16,.56)

1.00

AUD slope

.35 (.17, .53)

.50 (.37, .63)

.46 (−.08, .78)

1.00

MDD intercept

.30 (−.12, .70)

−.25 (−.59, .84)

1.00

MDD slope

.56 (.44, .68)

1.00

DUD intercept

1.00

DUD slope

Note: Key relationships of interest between BPD intercept and slope and the intercept and slope of MDD, AUD, and DUD are separated by vertical lines. All significant relationships are bolded.

.46 (.35, .56)

−.22 (−.42, −.02)

1.00

AUD intercept

BPD slope

BPD intercept

BPD intercept

Genetic correlations between the latent growth parameters for Borderline Personality Disorder (BPD) traits, Major Depressive Disorder (MDD)
symptoms, Alcohol Use Disorder (AUD) symptoms, and Drug Use Disorder (DUD) symptoms.
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.45 (.28, .62)

MDD intercept

.20 (.05,.37)

DUD slope

−.04 (−.25, .15)

−.13 (−.34, .05)

.47 (.22, .81)

.03 (−.19, .26)

−.06 (−.28, .14)

−.001 (−.22, .22)

1.00

BPD slope

.56 (.35, .79)

.68 (.48, .87)

.28 (−.02, .56)

.36 (.12, .60)

.93 (.81, .98)

1.00

AUD intercept

.57 (.36, .82)

.58 (.37, .80)

.01 (−.30, .31)

.11 (−.14, .36)

1.00

AUD slope

.04 (−.19, .27)

.36 (.15, .58)

.34 (.01, .66)

1.00

MDD intercept

−.14 (−.42, .12)

.01 (−.24, .28)

1.00

MDD slope

.57 (.41 .71)

1.00

DUD intercept

1.00

DUD slope

Note: Key relationships of interest between BPD intercept and slope and the intercept and slope of MDD, AUD, and DUD are separated by vertical lines. All significant relationships are bolded.

.21 (.06, .35)

DUD intercept

−.12 (−.35, .09)

.40 (.23, .58)

AUD slope

MDD slope

.41 (.24, .58)

.16 (−.07, .35)

1.00

AUD intercept

BPD slope

BPD intercept

BPD intercept

Nonshared environmental correlations between the latent growth parameters for Borderline Personality Disorder (BPD) traits, Major Depressive Disorder
(MDD) symptoms, Alcohol Use Disorder (AUD) symptoms, and Drug Use Disorder (DUD) symptoms.

Author Manuscript

Table 6
Bornovalova et al.
Page 33

Dev Psychopathol. Author manuscript; available in PMC 2018 February 01.

